about
Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.Cancer Immunotherapy and Personalized Medicine: Emerging Technologies and Biomarker-Based Approaches.Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity.Antitumor immunity and advances in cancer immunotherapy.Current status and future directions of cancer immunotherapy.
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Advances in personalized cancer immunotherapy.
@en
type
label
Advances in personalized cancer immunotherapy.
@en
prefLabel
Advances in personalized cancer immunotherapy.
@en
P2093
P2860
P1433
P1476
Advances in personalized cancer immunotherapy
@en
P2093
Hirokazu Matsushita
Takahiro Karasaki
Tomoharu Sugie
P2860
P2888
P356
10.1007/S12282-016-0688-1
P577
2016-03-21T00:00:00Z
P6179
1032467328